Markets:

Overview

News

Currencies

International

Treasuries

Evolent Health, Inc Class A Common Stock (NY:EVH)

3.265 -0.135 (-3.97%)

Streaming Delayed Price Updated: 10:36 AM EST, Mar 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Evolent Health, Inc Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Navigating 4 Analyst Ratings For Evolent Health ↗

March 15, 2024

Via Benzinga

HIMS Stock Breaks Out On Powerful Turnaround Quarter ↗

February 27, 2024

"In 2024, we expect to eclipse $1 billion in revenue and deliver our first full year of net income profitability.": CEO Andrew Dudum

Via Investor's Business Daily

These Analysts Revise Their Forecasts On Evolent Health After Upbeat Results ↗

February 23, 2024

Evolent Health, Inc. (NYSE: EVH) reported better-than-expected fourth-quarter results on Thursday.

Via Benzinga

Analyst Scoreboard: 4 Ratings For Evolent Health ↗

February 23, 2024

Via Benzinga

Evolent Health (EVH) Q4 2023 Earnings Call Transcript ↗

February 23, 2024

EVH earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 22, 2024

Via Benzinga

Evolent Health's Earnings: A Preview ↗

February 21, 2024

Via Benzinga

Analyst Expectations for Evolent Health's Future ↗

December 06, 2023

Via Benzinga

30 US States Pause Medicaid Disenrollment Due To Technical Glitch ↗

September 22, 2023

The U.S.

Via Benzinga

Evolent Health (EVH) Q2 2023 Earnings Call Transcript ↗

August 02, 2023

EVH earnings call for the period ending June 30, 2023.

Via The Motley Fool

Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

February 23, 2024

Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company reported fourth-quarter financial results.

Via Benzinga

Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

December 05, 2023

Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results.

Via Benzinga

Earnings Outlook For Evolent Health ↗

August 01, 2023

Via Benzinga

Analyst Ratings for Evolent Health ↗

June 26, 2023

Via Benzinga

Are You A Trader Or Investor: Biotech Momentum Is Picking Up ↗

November 20, 2023

ETFs have not helped as portfolio fillers but they can identify trends. We should play this rally out of a biotech bear market.

Via Talk Markets

Topics ETFs

Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday ↗

November 03, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Evolent Health (EVH) Q3 2023 Earnings Call Transcript ↗

November 03, 2023

EVH earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

Evolent Health (EVH) Q1 2023 Earnings Call Transcript ↗

May 04, 2023

EVH earnings call for the period ending March 31, 2023.

Via The Motley Fool

Recap: Evolent Health Q1 Earnings ↗

May 03, 2023

Via Benzinga

Evolent Health (EVH) Q4 2022 Earnings Call Transcript ↗

February 22, 2023

EVH earnings call for the period ending December 31, 2022.

Via The Motley Fool

Cowen & Co. Maintains Outperform Rating for Evolent Health: Here's What You Need To Know ↗

January 30, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 16, 2023 ↗

October 16, 2023

Via Benzinga

Growing Number of Industries Realize the Urgency for Ransomware Protection

July 12, 2023

EQNX::TICKER_START (NASDAQ:HCTI),(NASDAQ:HCAT),(NYSE:EVH),(NASDAQ:DH),(NASDAQ:NXGN) EQNX::TICKER_END

Via FinancialNewsMedia

Market Mixes It Up With A Broad Rally ↗

June 05, 2023

Biotech stocks remain sluggish but the longer-term outlook for breakthrough therapies - gene therapy, obesity, CNS, RNA - remain positive.

Via Talk Markets

Small & Mid Cap Life Science Stock Portfolio: Some Good Picks In A Stalled Sector ↗

May 01, 2023

A pivotal week looks to be shaping up with the usual macro concerns arising, such as a Fed meeting and big earnings waiting just around the corner. One possible path to help navigate around these macro...

Via Talk Markets

Biotech And Life Science Trades: Q1 2023 Performance By The Numbers ↗

April 01, 2023

Despite a strong month and a great finish to the quarter, many traders remain cautious about the market. It’s been a volatile time after the collapse of Silicon Valley Bank, but the first quarter of...

Via Talk Markets

Evolent Health Q4 Top-Line Beats Expectation, Analyst Points To Visible Growth Outlook ↗

February 23, 2023

Via Benzinga

SMID Cap Life Science Update: Are You An Investor Or Trader? ↗

February 20, 2023

Despite choppy trading, there is an upward tilt to life science stocks since the 9/26/22 lows.

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023 ↗

April 12, 2023

Via Benzinga

When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader? ↗

February 05, 2023

A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy?

Via Talk Markets

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Evolent Health, Inc Class A Common Stock (NY:EVH)

All News about Evolent Health, Inc Class A Common Stock

Resources